First Republic Investment Management, Inc. Sage Therapeutics, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $162,610 - $231,717	-4,039 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $1,756 - $2,537	-32 Reduced 0.79%	4,039 $229,000
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $24,162 - $33,091	342 Added 9.17%	4,071 $305,000
Q3 2020 Nov 12, 2020	BUY	$41.13 - $62.45 $153,373 - $232,876	3,729 New	3,729 $228,000
Q1 2020 May 13, 2020	SELL	$26.15 - $77.24 $122,277 - $361,174	-4,676 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $7,883 - $20,274	-131 Reduced 2.73%	4,676 $338,000
Q3 2019 Nov 08, 2019	SELL	$140.29 - $189.96 $65,515 - $88,711	-467 Reduced 8.85%	4,807 $674,000
Q2 2019 Aug 07, 2019	SELL	$157.85 - $183.09 $21,941 - $25,449	-139 Reduced 2.57%	5,274 $966,000
Q1 2019 Apr 30, 2019	BUY	$89.33 - $163.65 $268,793 - $492,422	3,009 Added 125.17%	5,413 $861,000
Q4 2018 Feb 12, 2019	SELL	$81.94 - $139.71 $19,993 - $34,089	-244 Reduced 9.21%	2,404 $230,000
Q3 2018 Nov 13, 2018	SELL	$138.11 - $169.04 $539,043 - $659,763	-3,903 Reduced 59.58%	2,648 $374,000
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $529,297 - $662,790	3,771 Added 135.65%	6,551 $1.03 Million
Q1 2018 May 10, 2018	SELL	$152.15 - $192.33 $24,648 - $31,157	-162 Reduced 5.51%	2,780 $448,000
Q4 2017 Feb 09, 2018	BUY	$60.72 - $167.34 $178,638 - $492,314	2,942	2,942 $485,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $284M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account